Blocking TIGIT/CD155 signalling reverses CD8(+) T cell exhaustion and enhances the antitumor activity in cervical cancer

OBJECTIVE: TIGIT/CD155 has attracted widespread attention as a new immune checkpoint and a potential target for cancer immunotherapy. In our study, we evaluated the role of TIGIT/CD155 checkpoints in the progression of cervical cancer. METHODS: The expression of CD155 and TIGIT in cervical cancer ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lu, Wang, Aihong, Liu, Xiaoli, Han, Sai, Sun, Yu, Zhang, Junhua, Guo, Lingyu, Zhang, Youzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210727/
https://www.ncbi.nlm.nih.gov/pubmed/35729552
http://dx.doi.org/10.1186/s12967-022-03480-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210727/
https://www.ncbi.nlm.nih.gov/pubmed/35729552
http://dx.doi.org/10.1186/s12967-022-03480-x

Ejemplares similares